Literature DB >> 15886971

Heart failure following anterior myocardial infarction: an indication for ventricular restoration, a surgical method to reverse post-infarction remodeling.

Alfred W H Stanley1, Constantine L Athanasuleas, Gerald D Buckberg.   

Abstract

Anterior myocardial infarction produces abrupt left ventricular (LV) dysynergy and global systolic dysfunction. Rapid intense neurohumoral activation, infarct expansion, and early ventricular chamber dilatation all contribute to restoring a normal stroke volume despite a persistently depressed ejection fraction. Continued neurohumoral activation provokes late remodeling of the remote non-infarcted myocardium, characterized by an abnormal progressively increasing LV volume/mass ratio that leads to further LV remodeling. Heart failure is a progressive disorder of LV remodeling. Heart failure from post-infarction remodeling is unique because of the persistent non-functioning scar that self- perpetuates abnormal loading conditions and neurohumoral activation. Medical therapy attenuates remodeling and improves survival but does not change the size of the scar. Surgical ventricular restoration to exclude the non-functioning infarct from the ventricular cavity decreases ventricular volumes, increases global ejection fraction, attenuates neurohumoral activation and yields an excellent 5-year survival. Combined medical and surgical therapy is recommended in this patient population.

Entities:  

Mesh:

Year:  2004        PMID: 15886971     DOI: 10.1007/s10741-005-6802-7

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  164 in total

1.  Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators.

Authors:  F Zannad; F Alla; B Dousset; A Perez; B Pitt
Journal:  Circulation       Date:  2000-11-28       Impact factor: 29.690

Review 2.  Mechanisms and therapy of myocardial reperfusion injury.

Authors:  M B Forman; R Virmani; D W Puett
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

Review 3.  Clinical benefits of thrombolytic therapy in acute myocardial infarction.

Authors:  A J Tiefenbrunn
Journal:  Am J Cardiol       Date:  1992-01-03       Impact factor: 2.778

4.  Quantitative echocardiography of the mitral complex in dilated cardiomyopathy: the mechanism of functional mitral regurgitation.

Authors:  C M Boltwood; C Tei; M Wong; P M Shah
Journal:  Circulation       Date:  1983-09       Impact factor: 29.690

Review 5.  Mitral valve reconstruction in the patient with heart failure.

Authors:  S F Bolling
Journal:  Heart Fail Rev       Date:  2001-09       Impact factor: 4.214

6.  Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.

Authors:  M A Konstam; M F Rousseau; M W Kronenberg; J E Udelson; J Melin; D Stewart; N Dolan; T R Edens; S Ahn; D Kinan
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

7.  Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.

Authors:  F Waagstein; K Caidahl; I Wallentin; C H Bergh; A Hjalmarson
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

8.  The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.

Authors:  M Packer
Journal:  J Am Coll Cardiol       Date:  1992-07       Impact factor: 24.094

Review 9.  How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease.

Authors:  M Packer
Journal:  Am J Cardiol       Date:  1993-03-25       Impact factor: 2.778

10.  Infarct expansion: pathologic analysis of 204 patients with a single myocardial infarct.

Authors:  J S Pirolo; G M Hutchins; G W Moore
Journal:  J Am Coll Cardiol       Date:  1986-02       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.